1. Home
  2. BCYC vs HELE Comparison

BCYC vs HELE Comparison

Compare BCYC & HELE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • HELE
  • Stock Information
  • Founded
  • BCYC 2009
  • HELE 1968
  • Country
  • BCYC United Kingdom
  • HELE United States
  • Employees
  • BCYC N/A
  • HELE N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • HELE Home Furnishings
  • Sector
  • BCYC Health Care
  • HELE Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • HELE Nasdaq
  • Market Cap
  • BCYC 565.5M
  • HELE 474.4M
  • IPO Year
  • BCYC 2019
  • HELE N/A
  • Fundamental
  • Price
  • BCYC $8.18
  • HELE $20.07
  • Analyst Decision
  • BCYC Buy
  • HELE Hold
  • Analyst Count
  • BCYC 11
  • HELE 3
  • Target Price
  • BCYC $22.91
  • HELE $42.00
  • AVG Volume (30 Days)
  • BCYC 284.7K
  • HELE 1.2M
  • Earning Date
  • BCYC 10-31-2025
  • HELE 10-09-2025
  • Dividend Yield
  • BCYC N/A
  • HELE N/A
  • EPS Growth
  • BCYC N/A
  • HELE N/A
  • EPS
  • BCYC N/A
  • HELE N/A
  • Revenue
  • BCYC $19,281,000.00
  • HELE $1,820,033,000.00
  • Revenue This Year
  • BCYC N/A
  • HELE N/A
  • Revenue Next Year
  • BCYC N/A
  • HELE $2.45
  • P/E Ratio
  • BCYC N/A
  • HELE N/A
  • Revenue Growth
  • BCYC N/A
  • HELE N/A
  • 52 Week Low
  • BCYC $6.10
  • HELE $18.90
  • 52 Week High
  • BCYC $25.39
  • HELE $75.68
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 53.38
  • HELE 41.19
  • Support Level
  • BCYC $7.65
  • HELE $19.68
  • Resistance Level
  • BCYC $8.42
  • HELE $21.12
  • Average True Range (ATR)
  • BCYC 0.49
  • HELE 1.03
  • MACD
  • BCYC -0.05
  • HELE 0.00
  • Stochastic Oscillator
  • BCYC 40.38
  • HELE 46.43

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

Share on Social Networks: